This post was originally published on this site
Further, growing cannabis requires significant capital expenditures for companies to benefit from economies of scale. Marijuana is also highly regulated and the slow rollout of retail store licenses in major Canadian provinces has severely impacted demand in the last three years.
However, the relaxation of lockdown rules in Canada and a rapidly expanding addressable market coupled with the prospects of marijuana legalization in the U.S., make Tilray (TLRY) and OrganiGram (OGI) intriguing potential long-term investments. Today I’ll analyze both stocks to determine which is currently the better buy.
